The Official Website of the Long-Term Investor
Results 41 - 50 of 545 : Previous 1 2 3 4 5 6 7 8 9 Next
Our investing community's latest prime pick to avoid: Dynavax Technologies.
A Bad Year for the 6,300% Miracle
Human Genome Sciences falls from grace.
What to Look For With Seattle Genetics in 2012
The launch of its new drug Adcetris will be key.
3 Stocks to Get on Your Watchlist
Are these three stocks set up for a large move?
Exelixis 2011: Not What the Doctor Ordered
A tale of an inability to get a Special Protocol Assessment from the FDA.
A No-Good, Really Bad, Awful Year for This Pharmaceutical Company
CEO's outrageous pricing guides this company down in 2011
3 Biotech Stocks That Had a Bad 2011
It's a volatile business, and these biotechs got the short end of the stick.
Biotech Royalties, Almost as Good as Cash
They're flexible, and all royalties have value.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK